Key Points
- Patricia Wadors, an SVP at Intuitive Surgical, sold 220 shares on Feb. 27 at an average price of $499.71 for a total of $109,936.20, as disclosed in an SEC filing.
- Intuitive Surgical reported a quarterly beat with EPS of $2.53 vs. $2.27 expected and revenue of $2.87 billion, up 18.8% year-over-year, with a net margin of 28.38%.
- Analyst sentiment is broadly positive — MarketBeat shows a "Moderate Buy" consensus and an average price target of $615.86, with most analysts rating the stock Buy/Outperform.
Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report) SVP Patricia Wadors sold 220 shares of the company's stock in a transaction that occurred on Friday, February 27th. The stock was sold at an average price of $499.71, for a total value of $109,936.20. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.
Intuitive Surgical Stock Performance
ISRG stock opened at $503.51 on Friday. The firm has a fifty day moving average price of $529.83 and a 200 day moving average price of $511.48. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $603.88. The firm has a market cap of $178.81 billion, a PE ratio of 63.82, a price-to-earnings-growth ratio of 3.91 and a beta of 1.65.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The company had revenue of $2.87 billion for the quarter, compared to the consensus estimate of $2.72 billion. During the same quarter in the prior year, the firm earned $2.21 earnings per share. Intuitive Surgical's revenue was up 18.8% on a year-over-year basis. On average, equities analysts predict that Intuitive Surgical, Inc. will post 6.43 EPS for the current year.
Wall Street Analyst Weigh In
Several research analysts recently commented on ISRG shares. Barclays set a $712.00 price target on Intuitive Surgical and gave the stock an "overweight" rating in a research report on Monday, January 26th. UBS Group set a $570.00 target price on Intuitive Surgical and gave the stock a "neutral" rating in a report on Tuesday. Robert W. Baird cut their target price on Intuitive Surgical from $655.00 to $645.00 and set an "outperform" rating on the stock in a research report on Friday, January 23rd. Sanford C. Bernstein increased their price target on Intuitive Surgical from $740.00 to $750.00 and gave the company an "outperform" rating in a report on Friday, January 23rd. Finally, HSBC raised their price target on Intuitive Surgical from $644.00 to $653.00 and gave the stock a "buy" rating in a research report on Monday, January 26th. Two analysts have rated the stock with a Strong Buy rating, fifteen have given a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company's stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average price target of $615.86.
Read Our Latest Research Report on Intuitive Surgical
Institutional Trading of Intuitive Surgical
A number of hedge funds and other institutional investors have recently bought and sold shares of ISRG. Groupama Asset Managment boosted its stake in shares of Intuitive Surgical by 11.7% during the fourth quarter. Groupama Asset Managment now owns 47,779 shares of the medical equipment provider's stock valued at $26,979,000 after purchasing an additional 4,993 shares during the period. Anchor Investment Management LLC lifted its holdings in Intuitive Surgical by 4.7% during the 4th quarter. Anchor Investment Management LLC now owns 6,330 shares of the medical equipment provider's stock valued at $3,585,000 after buying an additional 287 shares in the last quarter. Tempo Wealth LLC bought a new stake in Intuitive Surgical during the 4th quarter valued at about $201,000. MidFirst Bank purchased a new stake in Intuitive Surgical in the 4th quarter valued at about $5,138,000. Finally, DGS Capital Management LLC boosted its position in Intuitive Surgical by 184.7% in the 4th quarter. DGS Capital Management LLC now owns 3,183 shares of the medical equipment provider's stock valued at $1,803,000 after buying an additional 2,065 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.
Intuitive Surgical Company Profile
(
Get Free Report)
Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon's hand movements into finer, scaled motions of small instruments inside the patient. Intuitive's business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.
In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
